NAFDAC WARNS OF 4- Cough Syrups that could be Harmful to Health
Ejes Gist News reports that the National Agency for Food and Drug Administration and control (NAFDAC) has joined it’s international Partners The World health Organization (WHO) on its campaign against certain subpar cough syrups which WHO reported on September, 2022.
NAFDAC has informed the public, healthcare professionals, and the media that 66 children in the Gambia have died as a result of using the four subpar cough syrups.
The Drugs are…
- Promethazine Oral Solution,
- Kofexmalin Baby Cough Syrup,
- Makoff Baby Cough Syrup,
- Magrip N Cold Syrup
The caution was included in a statement made on Sunday by Prof. Mojisola Adeyeye, Director General of NAFDAC.
Laboratory analysis of samples of the four items, according to the statement, “confirms that they contain unacceptable amounts of diethylene glycol and ethylene glycol as contaminants.”
Are diethylene glycol and ethylene glycol good for human health?
Diethylene glycol and ethylene glycol are hazardous to humans when consumed and can be fatal, the warning continued.
Consequences of Taking the Subpar Cough Syrups
Abdominal discomfort, nausea, vomiting, diarrhoea, the inability to pass urine, headaches, changed mental status, and severe renal injury—which may result in death—can all be toxic consequences.
Maiden Pharmaceuticals Limited is the product’s listed manufacturer (Haryana, India). The claimed producer has not yet given WHO any assurances regarding the reliability and safety of these products.
The dangerous goods in this alert could cause serious harm or even death if used, especially by youngsters.
“The products should not be on the market since NAFDAC has not registered them.
These four products have so far only been found in The Gambia, but they may have travelled to other nations or areas via unofficial marketplaces.
“NAFDAC requests that everyone in the supply chain exercise caution and vigilance to prevent the importation, distribution, sale, and use of substandard cough syrups. This includes importers, distributors, retailers, and consumers.
“All medical items must be purchased from approved or authorized vendors. Carefully examine the products’ physical integrity and genuineness.
Warning by NAFDAC to the General Public!
“The general public is encouraged to stop selling or using the aforementioned goods and to turn in any remaining stock to the nearest NAFDAC office.
Please refrain from using these inferior products if you have them. You are encouraged to get immediate medical assistance from a licenced healthcare provider if you or someone you know has used these items or had any negative side effects.
Healthcare professionals and patients are urged to contact NAFDAC on 0800-162-3322 or by email at [email protected] if they have any suspicions about adverse drug reactions or substandard or counterfeit medicines.